BamSEC and AlphaSense Join Forces
Learn More

CoLucid Pharmaceuticals, Inc.

Formerly NASDAQ: CLCD
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 10 pages Tender and Support Agreement Article 1 Agreement to Tender
12/34/56
EX-10.2
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 10-Q 3 pages CoLucid Pharmaceuticals, Inc. 2015 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.14
from 10-K 8 pages November 7, 2015 Raymond Skwierczynski, PH.D. (Address Redacted) Dear Ray
12/34/56
EX-10.12
from 10-K 6 pages Agreement
12/34/56
EX-10.4
from 10-Q ~5 pages CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 5 pages Amended and Restated Consulting Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Pursuant to Our Recent Discussions, I Would Like to Outline Your Current Terms of Employment With CoLucid Pharmaceuticals, Inc. (“Colucid” or the “Company”). These Terms Supersede and Replace Those Set Forth in Your Previous Employment Letter Dated March 14, 2006. the Confidentiality, Inventions and Non-Competition Agreement, Dated February 20, 2006, Between the Company and You Will Remain in Full Force and Effect. Title/Position: You Will Have the Title of “Head, Research” and You Will Continue to Report to the Chief Executive Officer. Compensation
12/34/56
EX-10.1
from 10-Q 2 pages Pursuant to Our Recent Discussions, I Would Like to Outline Your Current Terms of Employment With CoLucid Pharmaceuticals, Inc. (“Colucid” or the “Company”). These Terms Supersede and Replace Those Set Forth in Your Previous Employment Letter Dated September 17, 2014. the Confidentiality, Inventions and Non-Competition Agreement, Dated October 15, 2014, Between the Company and You Will Remain in Full Force and Effect. Title/Position: You Will Have the Title of “Head, Clinical and Regulatory Operations” and You Will Continue to Report to the Chief Executive Officer. Compensation
12/34/56
EX-10.10
from S-1/A 53 pages Amended and Restated Development and License Agreement Between CoLucid Pharmaceuticals, Inc. and Eli Lilly and Company Effective as of February 10, 2015 Amended and Restated Development and License Agreement
12/34/56
EX-10.17
from S-1/A 4 pages CoLucid Pharmaceuticals, Inc. Restricted Stock Award Agreement Under the 2015 Equity Incentive Plan
12/34/56
EX-10.16
from S-1/A 4 pages CoLucid Pharmaceuticals, Inc. 2015 Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56
EX-10.15
from S-1/A 5 pages CoLucid Pharmaceuticals, Inc. Non-Statutory Stock Option Agreement Under the 2015 Equity Incentive Plan
12/34/56
EX-10.14
from S-1/A 5 pages CoLucid Pharmaceuticals, Inc. Incentive Stock Option Agreement Under the 2015 Equity Incentive Plan
12/34/56
EX-10.12
from S-1/A 1 page CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.4
from S-1/A 9 pages CoLucid Pharmaceuticals, Inc. Employee Stock Purchase Plan Effective: , 2015
12/34/56
EX-10.3
from S-1/A 15 pages CoLucid Pharmaceuticals, Inc. 2015 Equity Incentive Plan Effective: , 2015
12/34/56
EX-10.11
from S-1/A 22 pages (1) Pcas Group - And - (2) CoLucid Pharmaceuticals, Inc. Master Services Agreement
12/34/56
EX-10.10
from S-1/A 57 pages Amended and Restated Development and License Agreement Between CoLucid Pharmaceuticals, Inc. and Eli Lilly and Company Effective as of February 10, 2015 Amended and Restated Development and License Agreement
12/34/56